Esogress-HP Combipack Tablet is a combination medication containing Amoxycillin 750mg, Clarithromycin 500mg, and Esomeprazole 40mg, primarily indicated for the eradication of Helicobacter pylori infection associated with peptic ulcer disease and gastritis. Amoxycillin and Clarithromycin are broad-spectrum antibiotics that act synergistically to inhibit bacterial cell wall synthesis and protein synthesis respectively, effectively targeting H. pylori. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, thereby creating a less acidic environment that enhances antibiotic efficacy and promotes ulcer healing. This triple therapy is typically prescribed for 7 to 14 days, under medical supervision, to maximize eradication rates and minimize resistance development. Esogress-HP Combipack should be used with caution in patients with a history of hypersensitivity to penicillins, macrolides, or proton pump inhibitors. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. It is essential to complete the full course of therapy even if symptoms improve to prevent recurrence. Consultation with a healthcare professional is advised before initiating treatment to ensure appropriate use and monitoring.